Popularized in films like Limitless, legal smart drugs called Nootropics are becoming more and more prevalent in board rooms and on Wall Street.Keep reading »
I spoke to Lewis, 53, on April 2, at Bloomberg world headquarters in New York, the day after Bill O’Brien, the president of the BATS Global Markets, fumed at him and the white hat of his tale, Brad Katsuyama, in an entertaining confrontation on CNBC. Katsuyama, president and chief executive officer of IEX (Investors Exchange), is the main “flash boy.” […]
Hoelterhoff: In the meantime, are you feeling any shame? Bill O’Brien thinks you should.
Lewis: I was embarrassed for him. I mean I just thought the person was an embarrassing human being. His behavior sort of mimicked high-frequency trading, but in conversation — front-running everything everybody else said. I mean, he wouldn’t let anybody finish a sentence. It was astounding to me that someone like that actually runs a company. I just didn’t know what to say about it.